We are excited to announce that the first annual meeting of afib.no was a success – bringing together 48 atrial fibrillation researchers from Norway, Denmark and the Netherlands on October 19-20, 2017 at Lysebu, Oslo.

Professor of cardiac arrhythmias and clinical electrophysiologist, Jesper Hastrup Svendsen, from Rigshospitalet, Copenhagen University Hospital and the University of Copenhagen, Denmark, presented the large ongoing LOOP study, a randomized study investigating the health benefits and cost-effectiveness of implantable loop recorders as a screening tool for atrial fibrillation to prevent stroke in patients with risk factors for stroke.

Associate Professor and Clinical Director Michiel Rienstra, Department of Cardiology, University Medical Center Groningen (UMCG), the Netherlands, presented preliminary results from the RACE 3 trial, a randomized trial investigating routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure.

Furthermore, a total of 23 researchers from different groups in Norway presented their research projects and results, covering many AF research areas such as epidemiology, health registries & population-based studies, genetics, biomarkers, echocardiography, and clinical studies.

Save the dates for afib.no 2018, which will be held on September 27-28, 2018! See you in Oslo!

Categories: NEWS